iBio, Inc.
IBIO· Nasdaq
IBIOiBio, Inc.
Filed May 15, 2012 · 10-Q · 45 days after period end · 0000930413-12-003107
| Metric | Q3 2012 | Q3 2011 |
|---|---|---|
| Revenue | $371.76K | $176.00K |
| Net Income | -$3.10M | -$3.03M |
| EPS Diluted | -$0.07 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end
